{"_id":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgN6ZsesLDA","lastupdate":"2021-01-04T00:00:00.000Z","update_date":"2021-01-04T00:00:00.000Z","lastModified":"Feb 24, 2022","active":1,"confidence_score":90,"confidence_score_reason":"not claimed","urlname":"apostherapy","minimal_profile":null,"status":"","fullstatus":"","acquired":0,"hide_reason":null,"hide_reason_data":null,"hide_reasons":[{"id":"8257rxn4P8EFQOmS5hAAauHyYMhhxrA5u6yWX4XUShpybX3AMNo3Y9","reason":"Pending approval - External entity"},{"id":"aOIaOiiqfpA8UMw6VCTh8ueRmkG3lzDy1NGqEOaJbe11OrCzMTCCd6","reason":"The company is a service provider"},{"id":"ddgjKuc3GgH8E5UehSVJviRl471BCajL1plO8HtGoOojy2NivYqQ7x","reason":"Owner asked to delete"},{"id":"EjOKM211H1ira9J63oaGPuUxvr7Oba55TZo3NWsFO5uhbNu7o4x4zD","reason":"The company is not Israeli"},{"id":"J7fQJtnT3GdWWSE3MD8rzaW65LJ4jEIKxSZnneQiReONdZjG3zIqWe","reason":"Owner asked to hide in the meantime"},{"id":"NxlAC3ReFb5ksiYNLp2FnUyluoJzwRCYfcF7xpTZaPM53SdWQ5kv0B","reason":"Pending approval"},{"id":"RhC1tlwXzioK0MfzBII3H2wepEfQOfKVktmdwqeqTJjGi3ZaBWUqZo","reason":"The company is not innovative"},{"id":"S0Ed46vNI6vZYVxLedANWGjas23K6hY0QdsCtiGYL7lshqIEdLV3sA","reason":"The company ceased operations in Israel"},{"id":"VTANq7bEvlsEcPjp0ghelXfShaCosgndONGjgU730aAOxXtaDIF5j3","reason":"This is a product of an existing company"}],"type":"Startup","logokey":"$G2ATs0IjBjB04pcCA68iyLgxlN45OS0UrUOhb30Hsv0czO9ohX15nE","name":"AposHealth","oneliner":"Identification and Treatment of Gait-related Conditions","registrar":"514531508","website":"https://www.aposhealth.com/","careerspage":"https://www.aposhealth.com","founded_month":1,"founded_year":2004,"formernames":["AposTherapy"],"sociallinks":{"twitter":"https://twitter.com/AposHealthUS","youtube":"https://www.youtube.com/user/AposTherapyVideo","facebook":"https://www.facebook.com/AposTherapyUS","linkedin":"https://www.linkedin.com/company/1570368","instagram":"https://www.instagram.com/aposhealth"},"social":["https://www.youtube.com/user/AposTherapyVideo","https://www.facebook.com/AposTherapyUS","https://www.linkedin.com/company/1570368","https://www.instagram.com/aposhealth","https://twitter.com/AposHealthUS"],"flattenedsociallinks":"https://www.youtube.com/user/AposTherapyVideo|https://www.facebook.com/AposTherapyUS|https://www.linkedin.com/company/1570368|https://www.instagram.com/aposhealth|https://twitter.com/AposHealthUS","apps":{"appstore":"","googleplay":""},"is_claimed_by_owner":null,"employees":"51-200","employees_exact":116,"patent":0,"raised":37000000,"stage":"Mature","public_stage":"Mature","primary_sector_key":"agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","primary_sector":"Health Tech & Life Sciences","alternativenames":["Apos Health","Apos Medical Assets","Apos-Health","Apos.Health"],"about":"AposHealth is developing solutions for the identification and treatment of gait-related conditions.\r\n\r\nThe AposHealth foot-worn Apos3 device is FDA cleared for treating knee osteoarthritis, to help temporarily reduce knee pain and improve lower extremity function during activities of daily living. It is also a non-FDA-cleared wellness device that can help patients live well with other gait-related conditions such as chronic low back and hip pain.\r\n\r\nWith a mission to advance global health through the power of movement, AposHealth's latest business unit, AposIQ, combines innovative technology, data science, and over a decade of experience in gait modification to determine the optimal way to adjust patients' gaits over time.","climatetech_description":null,"is_climatetech_relevant":null,"phone":"+97299615100","country":null,"address":{"israeli":[{"id":"7e2ac70e-1348-4766-b9d6-6b85e3f48935","city":"Herzliya","type":null,"address":"Shderot Aba Eban 1, Herzliya, Israel","placeid":null,"notactive":0,"openeddate":null,"registrarid":null,"firstrdcenter":0,"registrarname":null},{"id":"dc3565a2-1b71-4f0d-a153-024fb2a56a75","city":"Jerusalem","type":null,"address":"Ha-Marpe Street 1, Jerusalem, Israel","placeid":null,"notactive":0,"openeddate":null,"registrarid":null,"firstrdcenter":0,"registrarname":null},{"id":"f67c5b7f-c967-4a46-b5e8-234cbdbbc30b","city":"Haifa","type":null,"address":"Leon Stein Street 9, Haifa, Israel","placeid":null,"notactive":0,"openeddate":null,"registrarid":null,"firstrdcenter":0,"registrarname":null}],"officesabroad":[{"id":"7f587e23-979e-471d-8222-4ee3a65bb693","city":"New York","address":"300 Park Avenue, New York, NY, USA","country":"United States","placeid":null}]},"headquarter_address":null,"district":"Center District,Jerusalem District,North District","news":[{"id":"f449d7ed-40ab-47f1-b951-35560aab455a","date":"Dec 7, 2020","link":"https://www.highmarkhealth.org/hmk/newsroom/pr/2020/2020-12-07-AposTherapy.shtml","source":"www.highmarkhealth.org","visible":1,"analysis":{"tags":"healthcare","company":"Highmark Health","layoffs":null,"summary":"Highmark Health is partnering with AposTherapy to bring a non-invasive, drug-free treatment option for knee osteoarthritis pain to patients. The AposTherapy device, cleared by the FDA, helps reduce knee pain and improve lower extremity function. The treatment program requires patients to wear a personalized device for one hour per day. Highmark Health aims to transform healthcare by driving better patient outcomes and lowering the total cost of care. The partnership with AposTherapy allows Highmark Health to offer an alternative non-invasive option for knee osteoarthritis treatment. The treatment is currently available to Highmark Inc. commercial health plan members in western Pennsylvania and will be explored for availability in other core markets in 2021.","partners":"AposTherapy","customers":"Highmark Inc. commercial health plan members","investors":null,"confidence":9,"key_topics":["AposTherapy","knee osteoarthritis","non-invasive treatment","partnership","patient care"],"date_of_event":"2020-12-07","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Partners","Customers"],"acquisition_amount":null,"structuredIssuesShow":"#Partners  #Customers","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"Wazx7xrUlcpzRLAkny2poNHxAEnzv4k6z9vRQLKHiaa3mQmLCe2jgW","news_summary":"Press Release","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"d97847db-1aaf-43a8-9be4-cb650d015cb3","date":"Aug 31, 2020","link":"https://www.globenewswire.com/news-release/2020/08/31/2086410/0/en/Healthfirst-New-York-Formalizes-Coverage-of-an-Innovative-Therapy-Called-AposTherapy-Designed-for-Use-in-Orthopedic-Conditions.html","source":"www.globenewswire.com","visible":1,"analysis":{"tags":"healthcare, medical devices","company":"AposTherapy","layoffs":null,"summary":"Healthfirst, New York’s largest not-for-profit health insurance company, will offer coverage for AposTherapy®, a foot-worn device for treating knee osteoarthritis and low back pain. The device temporarily shifts pressure from painful areas and provides a neuromuscular effect by re-educating muscles. Healthfirst initially provided AposTherapy® treatment to members with chronic knee pain due to osteoarthritis and later expanded coverage to members with chronic low back pain. The treatment program includes wearing the device for about an hour a day and attending physical therapy sessions. AposTherapy® is custom-calibrated for patients by trained clinicians. Recent research published in The Journal of the American Medical Association (JAMA) showed pain reduction and improvement in function for knee osteoarthritis patients treated with AposTherapy®. Healthfirst has seen lower utilization of resources, decreased pain medication use, and lower per member per month rates with the use of AposTherapy®.","partners":"AposTherapy","customers":"Healthfirst","investors":null,"confidence":9,"key_topics":["AposTherapy","Healthfirst","knee osteoarthritis","low back pain","treatment program"],"date_of_event":"August 31, 2020","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Customers","Partners"],"acquisition_amount":null,"structuredIssuesShow":"#Customers  #Partners","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"5gkkoQ8FvlUAFLI3AmSvVAY2gkPV7tlrF5HTDZztrHvi7E0OXNo2Tp","news_summary":"Healthfirst New York Formalizes Coverage of an Innovative Therapy Called AposTherapy® Designed for Use in Orthopedic Conditions","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"00efe8cd-1455-4d9c-b669-8d02780bd3ce","date":"Jun 9, 2020","link":"https://www.med-technews.com/news/partnership-innovates-for-knee-conditions/","source":"www.med-technews.com","visible":1,"analysis":{"tags":"healthcare, medical devices","company":"Apos Medical Assets","layoffs":null,"summary":"Apos Medical Assets is partnering with Spirit Access to improve health outcomes for patients with chronic knee conditions in the UK. The partnership aims to make the NHS Pathway for chronic knee conditions more efficient and reduce the number of knee replacement surgeries. AposTherapy, a clinically proven non-surgical knee pain treatment, has shown promising results in avoiding surgeries, saving costs, and reducing musculoskeletal, outpatient visits, radiology, injections, and opioid use. Apos Medical Assets recognizes the need for greater market access in the UK and is excited to work with Spirit Access to make AposTherapy available to more Clinical Commissioning Groups (CCGs).","partners":["Spirit Access"],"customers":null,"investors":null,"confidence":8,"key_topics":["NHS Pathway","chronic knee conditions","AposTherapy","savings","market access"],"date_of_event":null,"valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Partners","Customers"],"acquisition_amount":null,"structuredIssuesShow":"#Partners  #Customers","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"PSrHtERCj2MJeWXNG9XE9GMYMkd3BjBSyoMo9MjW46B3ESdiYdYk2G","news_summary":"Partnership innovates for knee conditions","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"79f3f210-79fe-4456-9e49-93dd00badce0","date":"May 18, 2020","link":"https://www.globenewswire.com/news-release/2020/05/18/2035079/0/en/Research-Published-in-The-Journal-of-the-American-Medical-Association-JAMA-Shows-Knee-Osteoarthritis-Patients-Treated-with-AposTherapy-Experienced-Significant-Pain-Reduction.html","source":"www.globenewswire.com","visible":1,"analysis":{"tags":"medical treatment","company":"AposTherapy","layoffs":null,"summary":"A study conducted by researchers from Boston University School of Medicine, the University of Bern Switzerland, and the University of Toronto found that AposTherapy significantly reduced pain associated with knee osteoarthritis and improved patients physical function and stiffness. The findings provide strong evidence supporting the effectiveness of the treatment. AposTherapy is an innovative, FDA-cleared temporary treatment for knee osteoarthritis and other musculoskeletal conditions. It uses a foot-worn medical device to shift pressure away from impacted areas and improve body mechanics and muscular coordination. The company aims to provide a value-based approach to musculoskeletal conditions and help patients with pain and functional impairment.","partners":null,"customers":null,"investors":null,"confidence":9,"key_topics":["knee osteoarthritis","pain relief","physical function","clinical research","musculoskeletal conditions"],"date_of_event":"May 18, 2020","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Customers"],"acquisition_amount":null,"structuredIssuesShow":"#Customers","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"pqS9Pz0EeLJPCXThCKsLKYEFNWV8Z3RxiOgqxaSbnZX9bvgX6x5agK","news_summary":"Research Published in The Journal of the American Medical Association (JAMA) Shows Knee Osteoarthritis Patients Treated with AposTherapy® Experienced Significant Pain Reduction","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"439b0f8e-b451-40c8-9edf-6200ea47e133","date":"May 5, 2020","link":"https://www.medilinkem.com/apos-medical-assets-partners-with-spirit-access-to-decrease-the-cost-of-knee-pain-treatments-in-the-uk/","source":"www.medilinkem.com","visible":1,"analysis":{"entityGrowthIconPath":"none;"},"sentiment":null,"analysisId":"LYcBMq54Ki83FjYOI2SoJ2UePccxBTabvju0SuR7ossZGsGNGYkNq1","news_summary":"You are being redirected...","analysisStructuredIssuesDisplay":"none","analysisImpactOnCompanyDisplay":"block"},{"id":"db994ee8-5ca1-4a57-89b6-0fcb19f677f3","date":"Mar 12, 2020","link":"https://www.globenewswire.com/news-release/2020/03/12/1999618/0/en/AposTherapy-Expands-Partnership-With-Professional-Physical-Therapy-to-Offer-Its-Drug-Free-Solution-to-Knee-and-Low-Back-Pain-Patients-at-Additional-Massachusetts-Locations.html","source":"www.globenewswire.com","visible":1,"analysis":{"tags":"partnership","company":"AposTherapy","layoffs":null,"summary":"AposTherapy has partnered with Professional Physical Therapy to offer a non-invasive, drug-free alternative to surgery for Massachusetts residents suffering from knee and low back pain. The program is available to members of Blue Cross Blue Shield of Massachusetts commercial, fully insured accounts. The AposTherapy program combines a patented footworn medical device and treatment program to address pain at the source and reeducate muscles for a healthier walking pattern. Clinical studies have shown significant reduction in pain and improvement in function and quality of life. The partnership aims to provide relief for knee and low back pain without opioids or invasive procedures.","partners":"Professional Physical Therapy","customers":"Blue Cross Blue Shield of Massachusetts","investors":null,"confidence":9,"key_topics":["AposTherapy","Professional Physical Therapy","Blue Cross Blue Shield","knee osteoarthritis","non-invasive treatment"],"date_of_event":"March 12, 2020","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Partners"],"acquisition_amount":null,"structuredIssuesShow":"#Partners","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"3eP545MWN6zX2HvEEc1Fd0NOLHhjcOAyIJbl2TI9H6EwCnqVZifGsM","news_summary":"AposTherapy® Expands Partnership With Professional Physical Therapy to Offer Its Drug-Free Solution to Knee and Low Back Pain Patients at Additional Massachusetts Locations","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"8a9b18d5-0e18-4fde-81af-9ace54e09763","date":"Mar 4, 2020","link":"https://www.globenewswire.com/news-release/2020/03/04/1995213/0/en/AposTherapy-Partners-With-Three-Physical-Therapy-Providers-in-Queens-to-Bring-a-Non-Surgical-Drug-Free-Solution-to-Knee-and-Lower-Back-Pain-Sufferers-in-New-York.html","source":"www.globenewswire.com","visible":1,"analysis":{"tags":"partnership","company":"AposTherapy","layoffs":null,"summary":"AposTherapy has partnered with three local physical therapy providers in Queens, New York to offer a non-invasive, drug-free alternative to surgery for residents suffering from knee and lower back pain. The program is available at All Hands on Physical Therapy, Sungil Hong PT, and Hands of Hope clinics. AposTherapy is an FDA-cleared treatment for knee osteoarthritis and other musculoskeletal conditions. It utilizes a foot-worn medical device and a treatment program to address the underlying causes of pain and improve function and quality of life. The partnerships aim to meet the growing need for knee pain relief without drugs or invasive procedures.","partners":["All Hands on Physical Therapy","Sungil Hong PT","Hands of Hope"],"customers":null,"investors":null,"confidence":8,"key_topics":["AposTherapy","partnership","non-invasive treatment","knee and lower back pain","New York clinics"],"date_of_event":"March 04, 2020","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Partners"],"acquisition_amount":null,"structuredIssuesShow":"#Partners","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"xbhSXyNsY6UFNBjq4bG4E4NoH5hRAip9vVW7Jq50w8aNApEXGmDSIe","news_summary":"AposTherapy® Partners With Three Physical Therapy Providers in Queens to Bring a Non-Surgical, Drug-Free Solution to Knee and Lower Back Pain Sufferers in New York","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"1a32a8d1-148b-4e6d-9b3a-fed0ba9f7577","date":"Feb 26, 2020","link":"https://www.globenewswire.com/news-release/2020/02/26/1991194/0/en/AposTherapy-and-Ahava-Medical-Rehabilitation-Center-Bring-a-Non-Surgical-Drug-Free-Solution-to-Knee-and-Lower-Back-Pain-Sufferers-in-Brooklyn.html","source":"www.globenewswire.com","visible":1,"analysis":{"tags":"non-invasive treatment","company":"Ahava Medical & Rehabilitation Center","layoffs":null,"summary":"Ahava Medical & Rehabilitation Center has partnered with AposTherapy to offer a non-invasive, drug-free alternative treatment for knee and lower back pain. The AposTherapy program combines a foot-worn medical device and a treatment program to address pain at the source and re-educate muscles for a healthier walking pattern. Clinical studies have shown significant reduction in pain and improvement in function and quality of life. Ahava Medical & Rehabilitation Center aims to provide personalized care to their community through this partnership.","partners":["AposTherapy"],"customers":null,"investors":null,"confidence":9,"key_topics":["AposTherapy","knee osteoarthritis","non-invasive treatment","partnership","pain relief"],"date_of_event":"February 26, 2020","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Customers"],"acquisition_amount":null,"structuredIssuesShow":"#Customers","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"U4kWOHS0w0G1Wzb2HhZHTki8umFyxKvuiYjg4b0pMBHyOsVhig3EeD","news_summary":"AposTherapy® and Ahava Medical & Rehabilitation Center Bring a Non-Surgical, Drug-Free Solution to Knee and Lower Back Pain Sufferers in Brooklyn","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"c5730238-baf9-42a9-94d2-6fccfd1a8a63","date":"Feb 19, 2020","link":"https://www.globenewswire.com/news-release/2020/02/19/1987203/0/en/AposTherapy-Launches-Unique-Patient-Activation-Program.html","source":"www.globenewswire.com","visible":1,"analysis":{"tags":"virtual care coordinator","company":"AposTherapy","layoffs":null,"summary":"AposTherapy and GoMo Health have launched the AposTherapy Concierge Care Program, a virtual care coordinator that guides patients through their healthcare journey. The program is expected to improve patient activation and outcomes while reducing the cost of healthcare delivery. AposTherapy is using GoMo Healths BehavioralRx patient engagement system to provide a seamless patient experience. The program offers personalized guidance, tips, and encouragement to patients based on their stage of the treatment process. AposTherapy is an innovative treatment for knee osteoarthritis and other musculoskeletal conditions. It works by shifting pressure away from painful areas and re-educating muscles to a healthier walking pattern. The treatment has shown significant pain relief and improvement in daily function and quality of life.","partners":["GoMo Health"],"customers":null,"investors":null,"confidence":8,"key_topics":["AposTherapy Concierge Care Program","GoMo Health","patient engagement system","personalized patient experience","reducing healthcare costs"],"date_of_event":"February 19, 2020","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Customers"],"acquisition_amount":null,"structuredIssuesShow":"#Customers","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"tqEhdr0ytsTcZPxr7ab0HyVCa1IR2jT1ai9vWiv2p0phyrHpxrBfXN","news_summary":"AposTherapy Launches Unique Patient Activation Program","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"5d09b3e5-2d61-47e0-bffb-d3a33ff7a2b1","date":"Feb 17, 2020","link":"https://www.globenewswire.com/news-release/2020/02/17/1985810/0/en/Apos-Medical-Assets-Ltd-Announces-11-Million-Series-A-Extension-Funding-Round-Led-by-Existing-Shareholders.html","source":"www.globenewswire.com","visible":1,"analysis":{"tags":"medical device","company":"Apos Medical Assets Ltd.","layoffs":null,"summary":"Apos Medical Assets Ltd., a global medical device company, has raised $11 million in a new funding round. The funding will be used to support the companys rapid expansion into new territories, increase sales capabilities, and invest in research and development for the next generation AposTherapy® device. AposTherapy® is an FDA-cleared treatment for knee osteoarthritis and other musculoskeletal conditions. The treatment combines a foot-worn medical device with a treatment program to provide pain relief and improve daily function and quality of life. With the funding, Apos Medical Assets Ltd. aims to increase distribution, payer coverage, and bring enhanced products and capabilities to the market.","partners":null,"customers":null,"investors":"aMoon","confidence":9,"key_topics":["funding","expansion","product development","market growth","treatment options"],"date_of_event":"2020-02-17","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":"$11 million","structured_issues":["Investment","Expand"],"acquisition_amount":null,"structuredIssuesShow":"#Investment  #Expand","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"J4H8PgONkCAFuksN1vLDzXLKqb3B5Dm8xyBrUb3FrNsMsLEJaTcNI6","news_summary":"Apos Medical Assets Ltd. Announces $11 Million Series A Extension Funding Round Led by Existing Shareholders","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"08674295-a89b-43b3-b28a-475b09d71bc9","date":"Apr 6, 2015","link":"https://www.cnbc.com/2015/04/06/apos-therapy-catches-the-eye-of-ex-pro-athletes.html","source":"www.cnbc.com","visible":1,"analysis":{"tags":["joint pain","non-invasive therapy"],"company":"Apos Therapy","layoffs":null,"summary":"Apos Therapy, an Israeli company, has developed a non-invasive at-home system for reducing joint pain. The system, which uses adjustable pods in the soles of boots to create a subtle imbalance, trains the brain to re-position muscles and correct back, hip, and knee alignment. Former pro athletes, including Tom Satch Sanders, have tried Apos Therapy and reported immediate relief. Over 80% of surveyed Apos patients in the UK reported a reduction in pain. Apos is now training physical therapists in the US to use their system, taking advantage of the existing infrastructure for physical therapy. The therapy is not currently covered by medical insurance in the US and costs up to $6,000.","partners":null,"customers":null,"investors":null,"confidence":8,"key_topics":["Apos Therapy","joint pain","non-invasive therapy","reducing pain","physical therapy"],"date_of_event":null,"valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Customers","Partners"],"acquisition_amount":null,"structuredIssuesShow":"#Customers  #Partners","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"DiQeTr44GOPruuYImPSCP0jBoLnNsCUtwXHhsG4YG5msUaiCsBMRV3","news_summary":"Apos Therapy catches the eye of ex-pro athletes","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"735ca8dc-f2ad-41ff-81b2-03f022bd511c","date":"Nov 25, 2014","link":"http://www.globes.co.il/en/article-knee-treatment-co-apostherapy-raises-15m-1000989010","source":"www.globes.co.il","visible":1,"analysis":{"tags":"treatment, knee and back pain","company":"AposTherapy","layoffs":null,"summary":"AposTherapy, a company that uses individually calibrated shoes to treat knee and back pain, has completed a $15 million financing round at an estimated $100 million company value. The company has raised $30 million to date and has 140 employees. AposTherapy is currently marketing its services in Israel, the UK, Singapore, the US, and other countries. The company is now focusing on expanding its business in the US market and plans to transfer its service activity to physiotherapy institutes while concentrating on research and development. AposTherapys treatment competes with pain relievers and complex surgery for ending pain, and the companys studies show that 86% of users reported less pain within five weeks.","partners":null,"customers":null,"investors":["Pitango Venture Capital","Aviv Venture Capital","Invus","David Levy","Richard Schnall"],"confidence":9,"key_topics":["shoe treatment","financing round","business strategy","expanding in US market","competition with pain relievers"],"date_of_event":"November 25, 2014","valuation_amount":"$100 million","impact_on_company":"growth-positive","investment_amount":"$15 million","structured_issues":["Investment","Expand"],"acquisition_amount":null,"structuredIssuesShow":"#Investment  #Expand","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"aZ9JIGgGQN35usIlGCrbHZ3d8Y1jV3FvyOZmHywuxdHjUEzJen1Pyo","news_summary":"Knee, back treatment co AposTherapy raises $15m","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"}],"newsNumber":12,"techcommunityinvolvement":null,"mediagallery":[{"id":"e350abc5-a646-43e2-a779-78618f1416ca","timestamp":"2021-01-04 11:30:02.000000","resources_type":2,"resources_title":"AposHealth Patient Montage","resources_file_name":"Tcsi_CH2z54","alt":"AposHealth Patient Montage logo","imageurl":"https://img.youtube.com/vi/Tcsi_CH2z54/0.jpg","url":"http://youtu.be/Tcsi_CH2z54"},{"id":"09cf0ca3-b1fd-40dc-b387-a4113b073bc2","timestamp":"2020-11-23 10:00:47.000000","resources_type":2,"resources_title":"How AposTherapy is Unique","resources_file_name":"VpUBnFXOki8","alt":"How AposTherapy is Unique logo","imageurl":"https://img.youtube.com/vi/VpUBnFXOki8/0.jpg","url":"http://youtu.be/VpUBnFXOki8"},{"id":"04c6936c-23e4-4105-a74b-7141cd386116","timestamp":"2020-08-09 06:39:39.000000","resources_type":2,"resources_title":"AposTherapy - How it Works","resources_file_name":"mjqIoxr9bYU","alt":"AposTherapy - How it Works logo","imageurl":"https://img.youtube.com/vi/mjqIoxr9bYU/0.jpg","url":"http://youtu.be/mjqIoxr9bYU"}],"tags":["orthopedics","pain-relief","personalization","home-care","medical-products","rehabilitation","non-surgical","therapeutic-devices","osteoarthritis","patients","chronic-pain","doctors","treatments","insurance-companies","wearable","seniors","wellness","healthcare-providers","remote-monitoring","digital-healthcare"],"classificationIDs":["agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah6ILDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfQhvYKDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Pv12fQLDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Pvo8q4JDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7rMLDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4NvT54kLDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IexhvsJDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4NuxivkKDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7tMLDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4PuD2a4JDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu18NgKDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4OuV-aALDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Iex9b0JDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8ivUIDA"],"technologysuccessstory":null,"usecases":[],"businessmodels":["B2C","B2B"],"productstage":"Released","products":["Apos3"],"geomarkets":["United Kingdom","United States","Singapore"],"targetmarkets":[],"marketcapital":null,"marketcapitaldate":null,"funding":{"investors":5,"lastfunding":"$11M","totalrounds":5,"fundingstage":"Mature","totalfunding":"$37M","publicinvestors":5,"lastpublicfunding":11000000,"totalpublicrounds":5,"totalpublicfunding":37000000},"team":[{"name":"Avi Elbaz","email":"","phone":"","gender":"Male","userid":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAgPGhpp4JDA","bounced":false,"claimed":0,"founder":1,"urlname":"avi-elbaz","visible":0,"memberid":"agxzfmlsbGlzdHNpdGVyFwsSCk5ld19NZW1iZXIYgICAsYXdoggM","position":"Co-Founder & Chairman","last_name":"Elbaz","claimtoken":"d781b4031a2eca2b06b615aa1661e07c836ce077f05e16fa91214c5ba9f2ca78","first_name":"Avi","picturekey":null,"claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/avi-elbaz-2ab98623/","unsubscribed":false,"is_activeuser":0,"additionalemail":"avie@apostherapy.com","claimedemaildate":"2020-08-09 06:33:34.000000","initials":"AE","pictureurl":"/assets/empty-state.svg","linkedin-display":"flex","teammembertagclass":"none","teammembertagcontent":"","channelId":"","visibilityClassName":"private-visibility","visibilityTooltip":"tooltip tooltip-html-content='<style>\n    .visibility-tooltip-container {\n        display: flex;\n        column-gap: 0.8rem;\n        padding: 0.8rem 1rem;\n        align-items: center;\n    } \n\n    .visibility-tooltip-container text {\n        font-size: 1.4rem;\n        text-transform: capitalize;\n        font-weight: 500;\n    }\n</style>\n\n<div class=\"visibility-tooltip-container\">\n    <img height=\"20\" width=\"20\" style=\"display: flex\" src=\"/assets/private-visibility.svg\"/>\n    <img height=\"20\" width=\"20\" style=\"display: none\" src=\"/assets/internal-visibility.svg\"/>\n    <text>private</text>\n</div>'"},{"name":"Michal Schnell","email":"michals@apostherapy.com","phone":"","gender":"Female","userid":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAoOGLzYUKDA","bounced":false,"claimed":0,"founder":0,"urlname":"michal-schnell","visible":1,"memberid":"agxzfmlsbGlzdHNpdGVyFwsSCk5ld19NZW1iZXIYgICg4a75jAoM","position":"CEO Israel","last_name":"Schnell","claimtoken":"94765ee482c5c7d462d6f79816bec207b1d9c3089676405cfb74bb01f83552c9","first_name":"Michal","picturekey":null,"claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/michal-schnell-a546485/","unsubscribed":false,"is_activeuser":1,"additionalemail":"","claimedemaildate":"2021-01-04 11:56:49.000000","initials":"MS","pictureurl":"/assets/empty-state.svg","linkedin-display":"flex","teammembertagclass":"connect","teammembertagcontent":"Connect","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"Cliff  Bleustein","email":"cliffm@aposhealth.com","phone":"","gender":"Male","userid":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICA4LO_hbgJDA","bounced":true,"claimed":0,"founder":0,"urlname":"cliff-bleustein","visible":1,"memberid":"agxzfmlsbGlzdHNpdGVyFwsSCk5ld19NZW1iZXIYgIDgs53OhAsM","position":"Global CEO & President","last_name":"Bleustein","claimtoken":"b2b630d667849a9fe30ec5a2c24a48fa43ff6ee891faa19057704380a1426038","first_name":"Cliff ","picturekey":null,"claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/cbleustein/","unsubscribed":false,"is_activeuser":1,"additionalemail":"","claimedemaildate":"2021-01-04 11:56:58.000000","initials":"CB","pictureurl":"/assets/empty-state.svg","linkedin-display":"flex","teammembertagclass":"none","teammembertagcontent":"","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"Amit  Mor","email":"","phone":"","gender":"Male","userid":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAgLG1y_gJDA","bounced":false,"claimed":0,"founder":1,"urlname":"amit-mor","visible":0,"memberid":"agxzfmlsbGlzdHNpdGVyFwsSCk5ld19NZW1iZXIYgICA8aHYmAkM","position":"Co-Founder & CMO","last_name":"Mor","claimtoken":"ee0018a3419469d83e20686ed229ee3de5df79db62be479f90a688c277aac0d1","first_name":"Amit ","picturekey":null,"claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/amit-mor-50b9492a/","unsubscribed":false,"is_activeuser":0,"additionalemail":"amitm@aposhealth.com","claimedemaildate":"2020-08-09 06:33:33.000000","initials":"AM","pictureurl":"/assets/empty-state.svg","linkedin-display":"flex","teammembertagclass":"none","teammembertagcontent":"","channelId":"","visibilityClassName":"private-visibility","visibilityTooltip":"tooltip tooltip-html-content='<style>\n    .visibility-tooltip-container {\n        display: flex;\n        column-gap: 0.8rem;\n        padding: 0.8rem 1rem;\n        align-items: center;\n    } \n\n    .visibility-tooltip-container text {\n        font-size: 1.4rem;\n        text-transform: capitalize;\n        font-weight: 500;\n    }\n</style>\n\n<div class=\"visibility-tooltip-container\">\n    <img height=\"20\" width=\"20\" style=\"display: flex\" src=\"/assets/private-visibility.svg\"/>\n    <img height=\"20\" width=\"20\" style=\"display: none\" src=\"/assets/internal-visibility.svg\"/>\n    <text>private</text>\n</div>'"},{"name":"Irit Shemesh","email":"irits@aopstherapy.com","phone":"","gender":"Female","userid":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICA4J2LjtoKDA","bounced":true,"claimed":0,"founder":0,"urlname":"irit-shemesh","visible":1,"memberid":"agxzfmlsbGlzdHNpdGVyFwsSCk5ld19NZW1iZXIYgIDg_ZPG1AoM","position":"Marketing Israel","last_name":"Shemesh","claimtoken":"fa0ec6f58a5b2c038ec7321fd7902d4a42375c04bab7a068fd41edc9e00a8c1c","first_name":"Irit","picturekey":null,"claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/irit-shemesh-paz-6186a736/","unsubscribed":false,"is_activeuser":1,"additionalemail":"","claimedemaildate":"2021-01-04 11:56:50.000000","initials":"IS","pictureurl":"/assets/empty-state.svg","linkedin-display":"flex","teammembertagclass":"none","teammembertagcontent":"","channelId":"","visibilityClassName":"","visibilityTooltip":""}],"description_edited":1,"tag_line_edited":1,"sector":"Digital Health and Medical Technologies","sectorverify":{"id":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAgLHD0KwIDA","fullname":"Sharon Shapira"},"biverify":{"id":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAgLHD0KwIDA","fullname":"Sharon Shapira"},"biverifydate":"2020-04-07T00:00:00.000Z","crunchbaseid":"apostherapy","lastupdator":"Yotam Maman","lastupdator_email":"yotamm1988@gmail.com","creator":"Tamar Weiss","creator_email":"tamar.e.weiss@gmail.com","createdate":"2014-07-15T00:00:00.000Z","biverification":"Sharon Shapira","sectorverification":"Sharon Shapira","affiliatedOrganizations":null,"timeline":[{"id":"nMnwmtJygkFrxR4DhIVNo42RQBJ5lWyIH2u9aBeE8JwNGPxR27dV9P","date":"Feb 2020","amount":"$11M","source":"https://www.globenewswire.com/news-release/2020/02/17/1985810/0/en/Apos-Medical-Assets-Ltd-Announces-11-Million-Series-A-Extension-Funding-Round-Led-by-Existing-Shareholders.html","eventtype":"FundingRoundEvent","investment":[{"name":"aMoon Fund","type":"Investor","amount":null,"hidden":false,"country":"Israel","fullurl":"/investor_page/amoon-partners","logokey":"$XFAsLr4oM0cpGPl8KooBiRDedzqYg8XejD5EGeDP9vLvSOQjBic7lH","tagline":null,"urlname":"/investor_page/amoon-partners","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAoIj37p8KDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"TJhLoF8InqNZgWSnIIToVegpJla6SHO8aj9WumosmsDncmTkI9x8aQ","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":1,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$XFAsLr4oM0cpGPl8KooBiRDedzqYg8XejD5EGeDP9vLvSOQjBic7lH","investmentVisibilityClassName":"","investmentVisibilityTooltip":"","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"A Round","style":"","hiddenCompanyTooltip":"","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","sectionname":"Private Equity Funding","amountnumber":11000000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOCkmsfJCww","date":"Aug 2016","amount":"$2.5M","source":"Migrated","eventtype":"FundingRoundEvent","investment":[],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"Debt Financing","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":2500000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgODE9ryTCww","date":"Nov 2014","amount":"$15M","source":"https://en.globes.co.il/en/article-knee-treatment-co-apostherapy-raises-15m-1000989010","eventtype":"FundingRoundEvent","investment":[{"name":"Aviv Venture Capital","type":"Investor","amount":0,"hidden":false,"country":"Israel","fullurl":"/investor_page/aviv-venture-capital","logokey":"$hF4ikKw3qe61KnDFsyRHkDE2UFDxLQmlw0FeTbXbQ21zzL6ETxO7Wc","tagline":null,"urlname":"/investor_page/aviv-venture-capital","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgOGVo4QJDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"2d1af149-2963-4dd0-a2a9-63fd51b286ad","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":1,"leadpartneruserid":null,"investorisfollowon":1,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$hF4ikKw3qe61KnDFsyRHkDE2UFDxLQmlw0FeTbXbQ21zzL6ETxO7Wc","leadcaption":"","followupcaption":"Follow on&nbsp;"},{"name":"Invus","type":"Investor","amount":0,"hidden":false,"country":"United States","fullurl":"/investor_page/invus","logokey":"$zkaAasvZ0NA9JBeyPq2kxaegtnlXGxyzXibE5iNP8VhQS1Jv8C59gK","tagline":"","urlname":"/investor_page/invus","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOCk2pCrCww","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"bd825611-0b00-46c6-97b0-dcb7d0503cc1","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":1,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$zkaAasvZ0NA9JBeyPq2kxaegtnlXGxyzXibE5iNP8VhQS1Jv8C59gK","leadcaption":"","followupcaption":""},{"name":"Pitango VC","type":"Investor","amount":0,"hidden":false,"country":"Israel","fullurl":"/investor_page/pitango-vc","logokey":"$JZnxeOlDwpDV6VuNwdabHlJ03Bmm8ocmMDsnBxQoBJLt4LFiM5Spop","tagline":null,"urlname":"/investor_page/pitango-vc","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgP6E1J0KDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"e05bbdaa-4c3a-49b5-8b6d-5ddb46172f1e","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":1,"leadpartneruserid":null,"investorisfollowon":1,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$JZnxeOlDwpDV6VuNwdabHlJ03Bmm8ocmMDsnBxQoBJLt4LFiM5Spop","leadcaption":"","followupcaption":"Follow on&nbsp;"}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"A Round","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":15000000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgODY5ZHDCQw","date":"Oct 2013","amount":"$5M","source":"Migrated","eventtype":"FundingRoundEvent","investment":[{"name":"Viola Credit","type":"Investor","amount":0,"hidden":false,"country":"Israel","fullurl":"/investor_page/viola-credit","logokey":"$lCeLvcmpASXQR3YZcKWBiMCGtuiju18Wdc1njx9cP2S22nw8dkPU10","tagline":null,"urlname":"/investor_page/viola-credit","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAoIm15cAJDA","fundingtype":"Institutional Investor","leadpartner":null,"investmentid":"dbc6f651-139e-471c-a037-fa3c19971c63","fundingsubtype":"Institutional Investor","investorislead":null,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$lCeLvcmpASXQR3YZcKWBiMCGtuiju18Wdc1njx9cP2S22nw8dkPU10","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"Debt Financing","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":5000000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOCE7r6PCww","date":"Dec 2011","amount":"$11M","source":"Migrated","eventtype":"FundingRoundEvent","investment":[{"name":"Pitango VC","type":"Investor","amount":0,"hidden":false,"country":"Israel","fullurl":"/investor_page/pitango-vc","logokey":"$JZnxeOlDwpDV6VuNwdabHlJ03Bmm8ocmMDsnBxQoBJLt4LFiM5Spop","tagline":null,"urlname":"/investor_page/pitango-vc","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgP6E1J0KDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"02b0b6d4-785d-4535-a69b-724c2b1a2e00","fundingsubtype":"VC and Private Equity","investorislead":null,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$JZnxeOlDwpDV6VuNwdabHlJ03Bmm8ocmMDsnBxQoBJLt4LFiM5Spop","leadcaption":"","followupcaption":""},{"name":"Aviv Venture Capital","type":"Investor","amount":0,"hidden":false,"country":"Israel","fullurl":"/investor_page/aviv-venture-capital","logokey":"$hF4ikKw3qe61KnDFsyRHkDE2UFDxLQmlw0FeTbXbQ21zzL6ETxO7Wc","tagline":null,"urlname":"/investor_page/aviv-venture-capital","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgOGVo4QJDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"ebe2b03b-76dd-4c02-bc2d-ffe3b4ae3e9d","fundingsubtype":"VC and Private Equity","investorislead":null,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$hF4ikKw3qe61KnDFsyRHkDE2UFDxLQmlw0FeTbXbQ21zzL6ETxO7Wc","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"A Round","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":11000000,"capitalraised":"Undisclosed","valuation":"Undisclosed"}],"investmentstage":[],"exits":[],"investments":[],"portfolio":[],"funds":[],"founded":"1/2004","databases":[],"sharedspaces":[],"utilities":[],"contributors":[],"employeesworldwide":"","fundingtype":"Startup","parsedName":"AposHealth","logourl":"https://storage.googleapis.com/clean-finder-353810/$G2ATs0IjBjB04pcCA68iyLgxlN45OS0UrUOhb30Hsv0czO9ohX15nE","oglogourl":"https://storage.googleapis.com/clean-finder-353810/$G2ATs0IjBjB04pcCA68iyLgxlN45OS0UrUOhb30Hsv0czO9ohX15nE","seoabout":"AposHealth is developing solutions for the identification and treatment of gait-related conditions.\r\n\r\nThe AposHealth foot-worn Apos3 device is FDA cleared...","seoTitle":"Israeli Startup","solutions":[],"teamMembersNumber":5,"primarySector":"Health Tech & Life Sciences","primary-sector-display":"block","classifications":[{"depth":0,"name":"Sector","queryString":"sectorclassification=undefined","classificationName":"sectorclassification"},{"depth":1,"name":"Health Tech & Life Sciences","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","classificationName":"sectorclassification"},{"depth":2,"name":"Digital Healthcare","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah6ILDA","classificationName":"sectorclassification"},{"depth":3,"name":"Patient Remote Monitoring","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4OuV-aALDA","classificationName":"sectorclassification"},{"depth":2,"name":"Medical Devices","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8ivUIDA","classificationName":"sectorclassification"},{"depth":3,"name":"Medical Treatment & Therapeutics","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfQhvYKDA","classificationName":"sectorclassification"},{"depth":3,"name":"Assistive Devices","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IexhvsJDA","classificationName":"sectorclassification"},{"depth":0,"name":"Core Technology","queryString":"coretechnology=undefined","classificationName":"coretechnology"},{"depth":1,"name":"Semiconductors & Electronics","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7rMLDA","classificationName":"coretechnology"},{"depth":2,"name":"Wearables","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Pv12fQLDA","classificationName":"coretechnology"},{"depth":0,"name":"Target Customer","queryString":"targetcustomer=undefined","classificationName":"targetcustomer"},{"depth":1,"name":"Healthcare & Life Sciences","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","classificationName":"targetcustomer"},{"depth":2,"name":"Healthcare","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA","classificationName":"targetcustomer"},{"depth":3,"name":"Insurance Companies","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4NuxivkKDA","classificationName":"targetcustomer"},{"depth":3,"name":"Providers","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7tMLDA","classificationName":"targetcustomer"},{"depth":3,"name":"Patients","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4PuD2a4JDA","classificationName":"targetcustomer"},{"depth":1,"name":"Consumers","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu18NgKDA","classificationName":"targetcustomer"},{"depth":2,"name":"Demographics & Family","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Pvo8q4JDA","classificationName":"targetcustomer"},{"depth":3,"name":"Seniors","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4NvT54kLDA","classificationName":"targetcustomer"},{"depth":3,"name":"Disabilities","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Iex9b0JDA","classificationName":"targetcustomer"}],"classificationDelimited":["SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Digital Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah6ILDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA","SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Medical Devices#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8ivUIDA>Medical Treatment & Therapeutics#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfQhvYKDA","TechnologyClassificationModel>Semiconductors & Electronics#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7rMLDA>Wearables#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Pv12fQLDA","IndustryClassificationModel>Consumers#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu18NgKDA>Demographics & Family#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Pvo8q4JDA","TechnologyClassificationModel>Semiconductors & Electronics#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7rMLDA","IndustryClassificationModel>Consumers#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu18NgKDA>Demographics & Family#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Pvo8q4JDA>Seniors#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4NvT54kLDA","SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Medical Devices#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8ivUIDA>Assistive Devices#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IexhvsJDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA>Insurance Companies#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4NuxivkKDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA>Providers#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7tMLDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA>Patients#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4PuD2a4JDA","IndustryClassificationModel>Consumers#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu18NgKDA","SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Digital Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah6ILDA>Patient Remote Monitoring#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4OuV-aALDA","IndustryClassificationModel>Consumers#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu18NgKDA>Demographics & Family#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Pvo8q4JDA>Disabilities#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Iex9b0JDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Medical Devices#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8ivUIDA"],"classificationsViewModel":"|0:>SectorClassificationModel|1:>SectorClassificationModel/Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA|2:>SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA/Digital Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah6ILDA|3:>SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Digital Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah6ILDA/Patient Remote Monitoring#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4OuV-aALDA|2:>SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA/Medical Devices#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8ivUIDA|3:>SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Medical Devices#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8ivUIDA/Medical Treatment & Therapeutics#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfQhvYKDA|3:>SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Medical Devices#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8ivUIDA/Assistive Devices#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IexhvsJDA|0:>IndustryClassificationModel|1:>IndustryClassificationModel/Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA|2:>IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA/Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA|3:>IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA/Insurance Companies#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4NuxivkKDA|3:>IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA/Providers#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7tMLDA|3:>IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA/Patients#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4PuD2a4JDA|1:>IndustryClassificationModel/Consumers#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu18NgKDA|2:>IndustryClassificationModel>Consumers#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu18NgKDA/Demographics & Family#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Pvo8q4JDA|3:>IndustryClassificationModel>Consumers#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu18NgKDA>Demographics & Family#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Pvo8q4JDA/Seniors#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4NvT54kLDA|3:>IndustryClassificationModel>Consumers#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu18NgKDA>Demographics & Family#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Pvo8q4JDA/Disabilities#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Iex9b0JDA|0:>TechnologyClassificationModel|1:>TechnologyClassificationModel/Semiconductors & Electronics#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7rMLDA|2:>TechnologyClassificationModel>Semiconductors & Electronics#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7rMLDA/Wearables#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Pv12fQLDA|","classificationTrees":{"sector":[{"title":"Health Tech & Life Sciences","key":"0-0","path":"SectorClassificationModel>Health Tech & Life Sciences","children":[{"title":"Digital Healthcare","key":"0-0-0","path":"SectorClassificationModel>Health Tech & Life Sciences>Digital Healthcare","children":[{"title":"Patient Remote Monitoring","key":"0-0-0-0","path":"SectorClassificationModel>Health Tech & Life Sciences>Digital Healthcare>Patient Remote Monitoring"}]},{"title":"Medical Devices","key":"0-0-1","path":"SectorClassificationModel>Health Tech & Life Sciences>Medical Devices","children":[{"title":"Medical Treatment & Therapeutics","key":"0-0-1-0","path":"SectorClassificationModel>Health Tech & Life Sciences>Medical Devices>Medical Treatment & Therapeutics"},{"title":"Assistive Devices","key":"0-0-1-1","path":"SectorClassificationModel>Health Tech & Life Sciences>Medical Devices>Assistive Devices"}]}]}],"targetCustomer":[{"title":"Healthcare & Life Sciences","key":"0-0","path":"IndustryClassificationModel>Healthcare & Life Sciences","children":[{"title":"Healthcare","key":"0-0-0","path":"IndustryClassificationModel>Healthcare & Life Sciences>Healthcare","children":[{"title":"Insurance Companies","key":"0-0-0-0","path":"IndustryClassificationModel>Healthcare & Life Sciences>Healthcare>Insurance Companies"},{"title":"Providers","key":"0-0-0-1","path":"IndustryClassificationModel>Healthcare & Life Sciences>Healthcare>Providers"},{"title":"Patients","key":"0-0-0-2","path":"IndustryClassificationModel>Healthcare & Life Sciences>Healthcare>Patients"}]}]},{"title":"Consumers","key":"0-1","path":"IndustryClassificationModel>Consumers","children":[{"title":"Demographics & Family","key":"0-1-0","path":"IndustryClassificationModel>Consumers>Demographics & Family","children":[{"title":"Seniors","key":"0-1-0-0","path":"IndustryClassificationModel>Consumers>Demographics & Family>Seniors"},{"title":"Disabilities","key":"0-1-0-1","path":"IndustryClassificationModel>Consumers>Demographics & Family>Disabilities"}]}]}],"coreTechnology":[{"title":"Semiconductors & Electronics","key":"0-0","path":"TechnologyClassificationModel>Semiconductors & Electronics","children":[{"title":"Wearables","key":"0-0-0","path":"TechnologyClassificationModel>Semiconductors & Electronics>Wearables"}]}]},"sectorClassifications":[{"depth":0,"name":"Sector","queryString":"sectorclassification=undefined","classificationName":"sectorclassification"},{"depth":1,"name":"Health Tech & Life Sciences","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","classificationName":"sectorclassification"},{"depth":2,"name":"Digital Healthcare","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah6ILDA","classificationName":"sectorclassification"},{"depth":3,"name":"Patient Remote Monitoring","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4OuV-aALDA","classificationName":"sectorclassification"},{"depth":2,"name":"Medical Devices","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8ivUIDA","classificationName":"sectorclassification"},{"depth":3,"name":"Medical Treatment & Therapeutics","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfQhvYKDA","classificationName":"sectorclassification"},{"depth":3,"name":"Assistive Devices","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IexhvsJDA","classificationName":"sectorclassification"}],"coreTechnologyClassifications":[{"depth":0,"name":"Core Technology","queryString":"coretechnology=undefined","classificationName":"coretechnology"},{"depth":1,"name":"Semiconductors & Electronics","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7rMLDA","classificationName":"coretechnology"},{"depth":2,"name":"Wearables","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Pv12fQLDA","classificationName":"coretechnology"}],"targetCustomerClassifications":[{"depth":0,"name":"Target Customer","queryString":"targetcustomer=undefined","classificationName":"targetcustomer"},{"depth":1,"name":"Healthcare & Life Sciences","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","classificationName":"targetcustomer"},{"depth":2,"name":"Healthcare","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA","classificationName":"targetcustomer"},{"depth":3,"name":"Insurance Companies","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4NuxivkKDA","classificationName":"targetcustomer"},{"depth":3,"name":"Providers","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7tMLDA","classificationName":"targetcustomer"},{"depth":3,"name":"Patients","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4PuD2a4JDA","classificationName":"targetcustomer"},{"depth":1,"name":"Consumers","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu18NgKDA","classificationName":"targetcustomer"},{"depth":2,"name":"Demographics & Family","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Pvo8q4JDA","classificationName":"targetcustomer"},{"depth":3,"name":"Seniors","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4NvT54kLDA","classificationName":"targetcustomer"},{"depth":3,"name":"Disabilities","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Iex9b0JDA","classificationName":"targetcustomer"}],"classificationNames":{"sector":["Health Tech & Life Sciences","Digital Healthcare","Patient Remote Monitoring","Medical Devices","Medical Treatment & Therapeutics","Assistive Devices"],"coreTechnology":["Semiconductors & Electronics","Wearables"],"targetCustomer":["Healthcare & Life Sciences","Healthcare","Insurance Companies","Providers","Patients","Consumers","Demographics & Family","Seniors","Disabilities"]},"section":null,"sectionParams":"","queryParams":"","popup_claim_profile":"false","claimedBadge":"none","display":{"mainContact":"none","climateTag":"none","seeMoreSimilarCompanisDisplay":"none","similarCompaniesTitleFontSize":"3.2rem","similarCompaniesTitle":"Similar Companies","similar_companies":[]},"mainContact":{},"_eventview":{"publicoffering_exit":[],"privateequityfunding":[{"id":"nMnwmtJygkFrxR4DhIVNo42RQBJ5lWyIH2u9aBeE8JwNGPxR27dV9P","date":"Feb 2020","amount":"$11M","source":"https://www.globenewswire.com/news-release/2020/02/17/1985810/0/en/Apos-Medical-Assets-Ltd-Announces-11-Million-Series-A-Extension-Funding-Round-Led-by-Existing-Shareholders.html","eventtype":"FundingRoundEvent","investment":[{"name":"aMoon Fund","type":"Investor","amount":null,"hidden":false,"country":"Israel","fullurl":"/investor_page/amoon-partners","logokey":"$XFAsLr4oM0cpGPl8KooBiRDedzqYg8XejD5EGeDP9vLvSOQjBic7lH","tagline":null,"urlname":"/investor_page/amoon-partners","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAoIj37p8KDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"TJhLoF8InqNZgWSnIIToVegpJla6SHO8aj9WumosmsDncmTkI9x8aQ","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":1,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$XFAsLr4oM0cpGPl8KooBiRDedzqYg8XejD5EGeDP9vLvSOQjBic7lH","investmentVisibilityClassName":"","investmentVisibilityTooltip":"","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"A Round","style":"","hiddenCompanyTooltip":"","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","sectionname":"Private Equity Funding","amountnumber":11000000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOCkmsfJCww","date":"Aug 2016","amount":"$2.5M","source":"Migrated","eventtype":"FundingRoundEvent","investment":[],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"Debt Financing","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":2500000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgODE9ryTCww","date":"Nov 2014","amount":"$15M","source":"https://en.globes.co.il/en/article-knee-treatment-co-apostherapy-raises-15m-1000989010","eventtype":"FundingRoundEvent","investment":[{"name":"Aviv Venture Capital","type":"Investor","amount":0,"hidden":false,"country":"Israel","fullurl":"/investor_page/aviv-venture-capital","logokey":"$hF4ikKw3qe61KnDFsyRHkDE2UFDxLQmlw0FeTbXbQ21zzL6ETxO7Wc","tagline":null,"urlname":"/investor_page/aviv-venture-capital","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgOGVo4QJDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"2d1af149-2963-4dd0-a2a9-63fd51b286ad","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":1,"leadpartneruserid":null,"investorisfollowon":1,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$hF4ikKw3qe61KnDFsyRHkDE2UFDxLQmlw0FeTbXbQ21zzL6ETxO7Wc","leadcaption":"","followupcaption":"Follow on&nbsp;"},{"name":"Invus","type":"Investor","amount":0,"hidden":false,"country":"United States","fullurl":"/investor_page/invus","logokey":"$zkaAasvZ0NA9JBeyPq2kxaegtnlXGxyzXibE5iNP8VhQS1Jv8C59gK","tagline":"","urlname":"/investor_page/invus","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOCk2pCrCww","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"bd825611-0b00-46c6-97b0-dcb7d0503cc1","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":1,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$zkaAasvZ0NA9JBeyPq2kxaegtnlXGxyzXibE5iNP8VhQS1Jv8C59gK","leadcaption":"","followupcaption":""},{"name":"Pitango VC","type":"Investor","amount":0,"hidden":false,"country":"Israel","fullurl":"/investor_page/pitango-vc","logokey":"$JZnxeOlDwpDV6VuNwdabHlJ03Bmm8ocmMDsnBxQoBJLt4LFiM5Spop","tagline":null,"urlname":"/investor_page/pitango-vc","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgP6E1J0KDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"e05bbdaa-4c3a-49b5-8b6d-5ddb46172f1e","fundingsubtype":"VC and Private Equity","investorislead":0,"amountvisibility":"Public","isextensionround":1,"leadpartneruserid":null,"investorisfollowon":1,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$JZnxeOlDwpDV6VuNwdabHlJ03Bmm8ocmMDsnBxQoBJLt4LFiM5Spop","leadcaption":"","followupcaption":"Follow on&nbsp;"}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"A Round","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":15000000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgODY5ZHDCQw","date":"Oct 2013","amount":"$5M","source":"Migrated","eventtype":"FundingRoundEvent","investment":[{"name":"Viola Credit","type":"Investor","amount":0,"hidden":false,"country":"Israel","fullurl":"/investor_page/viola-credit","logokey":"$lCeLvcmpASXQR3YZcKWBiMCGtuiju18Wdc1njx9cP2S22nw8dkPU10","tagline":null,"urlname":"/investor_page/viola-credit","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAoIm15cAJDA","fundingtype":"Institutional Investor","leadpartner":null,"investmentid":"dbc6f651-139e-471c-a037-fa3c19971c63","fundingsubtype":"Institutional Investor","investorislead":null,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$lCeLvcmpASXQR3YZcKWBiMCGtuiju18Wdc1njx9cP2S22nw8dkPU10","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"Debt Financing","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":5000000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgOCE7r6PCww","date":"Dec 2011","amount":"$11M","source":"Migrated","eventtype":"FundingRoundEvent","investment":[{"name":"Pitango VC","type":"Investor","amount":0,"hidden":false,"country":"Israel","fullurl":"/investor_page/pitango-vc","logokey":"$JZnxeOlDwpDV6VuNwdabHlJ03Bmm8ocmMDsnBxQoBJLt4LFiM5Spop","tagline":null,"urlname":"/investor_page/pitango-vc","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgP6E1J0KDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"02b0b6d4-785d-4535-a69b-724c2b1a2e00","fundingsubtype":"VC and Private Equity","investorislead":null,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$JZnxeOlDwpDV6VuNwdabHlJ03Bmm8ocmMDsnBxQoBJLt4LFiM5Spop","leadcaption":"","followupcaption":""},{"name":"Aviv Venture Capital","type":"Investor","amount":0,"hidden":false,"country":"Israel","fullurl":"/investor_page/aviv-venture-capital","logokey":"$hF4ikKw3qe61KnDFsyRHkDE2UFDxLQmlw0FeTbXbQ21zzL6ETxO7Wc","tagline":null,"urlname":"/investor_page/aviv-venture-capital","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgOGVo4QJDA","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"ebe2b03b-76dd-4c02-bc2d-ffe3b4ae3e9d","fundingsubtype":"VC and Private Equity","investorislead":null,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$hF4ikKw3qe61KnDFsyRHkDE2UFDxLQmlw0FeTbXbQ21zzL6ETxO7Wc","leadcaption":"","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"A Round","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":11000000,"capitalraised":"Undisclosed","valuation":"Undisclosed"}],"nonequityfunding":[],"merger_acquisitions":[],"others":[]}}